WallStreetZenWallStreetZen

NASDAQ: XRAY
Dentsply Sirona Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for XRAY

Based on 8 analysts offering 12 month price targets for Dentsply Sirona Inc.
Min Forecast
$41.00+40.65%
Avg Forecast
$51.13+75.39%
Max Forecast
$67.00+129.85%

Should I buy or sell XRAY stock?

Based on 9 analysts offering ratings for Dentsply Sirona Inc.
Buy
Strong Buy
2 analysts 22.22%
Buy
2 analysts 22.22%
Hold
4 analysts 44.44%
Sell
1 analysts 11.11%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XRAY stock forecasts and price targets.

XRAY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
William Blair
Bottom 22%
22
SellDowngradesN/AN/A2022-08-05
Goldman Sachs
Bottom 8%
8
HoldMaintains$41.00+40.65%2022-07-21
Morgan Stanley
Top 4%
97
Strong BuyMaintains$44.00+50.94%2022-07-20
UBS
Bottom 25%
25
Strong BuyUpgrades$47.00+61.23%2022-06-02
Anonymous
Morgan Stanley
Strong BuyMaintains$48.00+64.67%2022-05-11
HC Wainwright & Co.
Top 5%
96
HoldMaintains$48.00+64.67%2022-04-22
Bank of America
Bottom 17%
17
HoldDowngrades$49.00+68.10%2022-04-20
Piper Sandler
Bottom 11%
11
HoldDowngrades$46.00+57.80%2022-04-20
HoldDowngrades$48.00+64.67%2022-04-19
Credit Suisse
Bottom 6%
6
BuyMaintains$67.00+129.85%2022-03-01

1 of 2

Forecast return on equity

Is XRAY forecast to generate an efficient return?
Company
14.41%
Industry
20.46%
Market
121.65%
XRAY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XRAY forecast to generate an efficient return on assets?
Company
7.88%
Industry
11.64%
XRAY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XRAY earnings per share forecast

What is XRAY's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$2.39+23.83%
Avg 2 year Forecast
$2.64+36.79%
Avg 3 year Forecast
$2.89+49.74%
XRAY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

XRAY revenue forecast

What is XRAY's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$4.1B-2.75%
Avg 2 year Forecast
$4.3B+0.49%
Avg 3 year Forecast
$4.5B+5.16%
XRAY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XRAY earnings growth forecast

How is XRAY forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
14.41%
Industry
22.66%
Market
16.67%
XRAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
XRAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
XRAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

XRAY revenue growth forecast

How is XRAY forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
1.54%
Industry
4.31%
Market
8.48%
XRAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XRAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XRAY vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
XRAY$29.15$51.13+75.39%Buy
BLCO$15.61$23.22+48.76%Buy
NVST$33.19$47.33+42.61%Strong Buy
MASI$142.42$194.50+36.57%Strong Buy
STVN$17.52$23.50+34.13%Strong Buy

Dentsply Sirona Stock Forecast FAQ

Is Dentsply Sirona Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: XRAY) stock is to Buy XRAY stock.

Out of 9 analysts, 2 (22.22%) are recommending XRAY as a Strong Buy, 2 (22.22%) are recommending XRAY as a Buy, 4 (44.44%) are recommending XRAY as a Hold, 1 (11.11%) are recommending XRAY as a Sell, and 0 (0%) are recommending XRAY as a Strong Sell.

If you're new to stock investing, here's how to buy Dentsply Sirona stock.

What is XRAY's earnings growth forecast for 2022-2024?

(NASDAQ: XRAY) Dentsply Sirona's forecast annual earnings growth rate of 14.41% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 22.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.67%.

Dentsply Sirona's earnings in 2022 is $421,000,000.On average, 8 Wall Street analysts forecast XRAY's earnings for 2022 to be $519,954,784, with the lowest XRAY earnings forecast at $496,023,811, and the highest XRAY earnings forecast at $533,008,042. On average, 8 Wall Street analysts forecast XRAY's earnings for 2023 to be $574,343,360, with the lowest XRAY earnings forecast at $535,183,585, and the highest XRAY earnings forecast at $598,274,333.

In 2024, XRAY is forecast to generate $628,731,936 in earnings, with the lowest earnings forecast at $611,327,591 and the highest earnings forecast at $641,785,194.

What is XRAY's revenue growth forecast for 2022-2024?

(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.54% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 4.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.48%.

Dentsply Sirona's revenue in 2022 is $4,251,000,000.On average, 7 Wall Street analysts forecast XRAY's revenue for 2022 to be $899,345,775,183, with the lowest XRAY revenue forecast at $887,512,779,089, and the highest XRAY revenue forecast at $903,311,572,572. On average, 7 Wall Street analysts forecast XRAY's revenue for 2023 to be $929,333,460,308, with the lowest XRAY revenue forecast at $914,576,534,382, and the highest XRAY revenue forecast at $945,519,282,897.

In 2024, XRAY is forecast to generate $972,546,053,959 in revenue, with the lowest revenue forecast at $956,151,161,685 and the highest revenue forecast at $989,223,766,827.

What is XRAY's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: XRAY) forecast ROA is 7.88%, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.64%.

What is XRAY's Price Target?

According to 8 Wall Street analysts that have issued a 1 year XRAY price target, the average XRAY price target is $51.13, with the highest XRAY stock price forecast at $67.00 and the lowest XRAY stock price forecast at $41.00.

On average, Wall Street analysts predict that Dentsply Sirona's share price could reach $51.13 by Aug 5, 2023. The average Dentsply Sirona stock price prediction forecasts a potential upside of 75.39% from the current XRAY share price of $29.15.

What is XRAY's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: XRAY) Dentsply Sirona's current Earnings Per Share (EPS) is $1.93. On average, analysts forecast that XRAY's EPS will be $2.39 for 2022, with the lowest EPS forecast at $2.28, and the highest EPS forecast at $2.45. On average, analysts forecast that XRAY's EPS will be $2.64 for 2023, with the lowest EPS forecast at $2.46, and the highest EPS forecast at $2.75. In 2024, XRAY's EPS is forecast to hit $2.89 (min: $2.81, max: $2.95).

What is XRAY's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: XRAY) forecast ROE is 14.41%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.